Zydus inks licensing, commercialisation pact with RK Pharma
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
Dragon Copilot integrates generative AI, ambient listening, and natural language processing (NLP) to capture and document care directly
Bayer remains a key partner in Ginkgo Bioworks’ growing agricultural biologicals platform
The antibody was designed and developed at Abzena’s Cambridge, UK,
Takeda will make an upfront payment of $1.2 billion, which includes a $100 million equity investment in Innovent
Contera Pharma will receive an upfront payment and full research funding for each target under investigation
Novelix will provide financial and infrastructural support for the entire technology transfer and scale-up program
Early stage projects of up to Rs. 9 crore eligible for up to Rs. 5 crore assistance and later stage projects of up to Rs. 285 crore eligible for up to Rs. 100 crore assistance
Subscribe To Our Newsletter & Stay Updated